Your browser doesn't support javascript.
Rapid and Effective Inactivation of SARS-CoV-2 with a Cationic Conjugated Oligomer with Visible Light: Studies of Antiviral Activity in Solutions and on Supports.
Kaya, Kemal; Khalil, Mohammed; Fetrow, Benjamin; Fritz, Hugh; Jagadesan, Pradeepkumar; Bondu, Virginie; Ista, Linnea; Chi, Eva Y; Schanze, Kirk S; Whitten, David G; Kell, Alison.
  • Kaya K; Department of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico 87131-0001, United States.
  • Khalil M; Department of Biochemistry, Kutahya Dumlupinar University, Kutahya 43000, Turkey.
  • Fetrow B; Center for Biomedical Engineering and Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131-0001, United States.
  • Fritz H; Center for Biomedical Engineering and Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131-0001, United States.
  • Jagadesan P; Department of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico 87131-0001, United States.
  • Bondu V; Department of Chemistry, University of Texas at San Antonio, San Antonio, Texas 78249-1644, United States.
  • Ista L; Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131-0001, United States.
  • Chi EY; Center for Biomedical Engineering and Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131-0001, United States.
  • Schanze KS; Center for Biomedical Engineering and Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131-0001, United States.
  • Whitten DG; Department of Chemistry, University of Texas at San Antonio, San Antonio, Texas 78249-1644, United States.
  • Kell A; Center for Biomedical Engineering, Department of Chemistry and Chemical Biology, and Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131-0001, United States.
ACS Appl Mater Interfaces ; 14(4): 4892-4898, 2022 Feb 02.
Article in English | MEDLINE | ID: covidwho-1633913
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
This paper presents results of a study of a new cationic oligomer that contains end groups and a chromophore affording inactivation of SARS-CoV-2 by visible light irradiation in solution or as a solid coating on paper wipes and glass fiber filtration substrates. A key finding of this study is that the cationic oligomer with a central thiophene ring and imidazolium charged groups gives outstanding performance in both the killing of E. coli bacterial cells and inactivation of the virus at very short times. Our introduction of cationic N-methyl imidazolium groups enhances the light activation process for both E. coli and SARS-CoV-2 but dampens the killing of the bacteria and eliminates the inactivation of the virus in the dark. For the studies with this oligomer in solution at a concentration of 1 µg/mL and E. coli, we obtain 3 log killing of the bacteria with 10 min of irradiation with LuzChem cool white lights (mimicking indoor illumination). With the oligomer in solution at a concentration of 10 µg/mL, we observe 4 log inactivation (99.99%) in 5 min of irradiation and total inactivation after 10 min. The oligomer is quite active against E. coli on oligomer-coated paper wipes and glass fiber filter supports. The SARS-CoV-2 is also inactivated by oligomer-coated glass fiber filter papers. This study indicates that these oligomer-coated materials may be very useful as wipes and filtration materials.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Limits: Humans Language: English Journal: ACS Appl Mater Interfaces Journal subject: Biotechnology / Biomedical Engineering Year: 2022 Document Type: Article Affiliation country: Acsami.1c19716

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Limits: Humans Language: English Journal: ACS Appl Mater Interfaces Journal subject: Biotechnology / Biomedical Engineering Year: 2022 Document Type: Article Affiliation country: Acsami.1c19716